Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery

Journal of Drug Targeting

Volumn 22, Issue 7, 2014, Pages 669-677

  Cho, Hyunah ^a   Kwon, Glen S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

17 AAG; Multi drug delivery; Ovarian cancer; Paclitaxel; PLGA b PEG b PLGA; Raamycin; Regel

Indexed keywords

MACROGOL; PACLITAXEL; POLYGLACTIN; RAPAMYCIN; TANESPIMYCIN; TRIOLIMUS; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; DRUG CARRIER; DRUG COMBINATION; HYDROGEL; MACROCYCLIC LACTAM; MACROGOL DERIVATIVE; POLY(LACTIDE-CO-GLYCOLIDE)-BLOCK-POLY(ETHYLENE GLYCOL)-BLOCK-POLY(LACTIDE-CO-GLYCOLIDE); POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BODY TEMPERATURE; CANCER MODEL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; ENVIRONMENTAL TEMPERATURE; FEMALE; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDROGEL; IC 50; IN VITRO STUDY; MICELLE; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; SLOW DRUG RELEASE; SURVIVAL TIME; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; DRUG RELEASE; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PHASE TRANSITION; TRANSITION TEMPERATURE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZOQUINONES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG COMBINATIONS; DRUG LIBERATION; FEMALE; HUMANS; HYDROGELS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LACTAMS, MACROCYCLIC; MICE, NUDE; MOLECULAR STRUCTURE; PACLITAXEL; PHASE TRANSITION; POLYESTERS; POLYETHYLENE GLYCOLS; SIROLIMUS; TRANSITION TEMPERATURE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904352731     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.931406     Document Type: Article

References (16)

1. American Cancer Society. Cancer facts and figures 2013. Atlanta: American Cancer Society; 2013
2. Lu Z, Wang J, Wientjes MG, et al. Intraperitoneal therapy for peritoneal cancer. Future Oncol 2010;6:1625-41
3. Cho H, Lai TC, Kwon GS. Poly(ethylene glycol)-block-poly(epsilon- caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. J Control Release 2013;166: 1-9
4. Markman M. Intraperitoneal antineoplastic drug delivery: Rationale and results. Lancet Oncol 2003;4:277-83
5. Hamilton CA, Berek JS. Intraperitoneal chemotherapy for ovarian cancer. Curr Opin Oncol 2006;18:507-15
6. Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 1971;178:562-4
7. Yu L, Ci TY, Zhou SC, et al. The thermogelling PLGA-PEG-PLGA block copolymer as a sustained release matrix of doxorubicin. Biomater Sci-UK 2013;1:411-20
8. Elstad NL, Fowers KD. OncoGel (ReGel/paclitaxel)-clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev 2009;61:785-94
9. Qiao MX, Chen DW, Ma XC, et al. Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int J Pharm 2005;294:103-12
10. Yu L, Ding JD. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008;37:1473-81
11. Gao Y, Ren F, Ding B, et al. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel. J Drug Target 2011;19: 516-27
12. Gao Y, Sun Y, Ren F, et al. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate. Drug Dev Ind Pharm 2010;36:1131-8
13. van Goor, H. Consequences and complications of peritoneal adhesions. Colorectal Dis 2007;9:25-34
14. diZeregal GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 2001;7: 547-55
15. Yeo Y, Kohane DS. Polymers in the prevention of peritoneal adhesions. Eur J Pharm Biopharm 2008;68:57-66
16. Shin HC, Alani AWG, Cho H, et al. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs. Mol Pharmaceut 2011;8:1257-65.